Cite

HARVARD Citation

    Grössmann, N. et al. (2019). Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015. European journal of cancer. pp. 1-7. [Online]. 
  
Back to record